The Unmet Needs in Neuroblastoma, a Compartmental View - Symposium Supported by Y-mAbs Therapeutics, Inc. Session Description: Join us as experts discuss specific unmet needs within high-risk neuroblastoma. CNS/LM neuroblastoma metastases are rare, but diagnosis is associated with a dismal prognosis. This section will review data on the incidence, imaging techniques, prognosis, and patterns of metastasis. The second section will focus on the prognostic value of the presence of bone and/bone marrow disease including at diagnosis, relapse, or persistent disease after prior treatment. In the last section, we will discuss the current data on minimal residual disease including testing methods and prognostic implications.